Applied Operating Cycle from 2010 to 2026

BNBX Stock   1.56  0.06  3.70%   
Applied DNA Operating Cycle yearly trend continues to be fairly stable with very little volatility. Operating Cycle will likely drop to 117.95 in 2026. During the period from 2010 to 2026, Applied DNA Operating Cycle regression line of annual values had r-squared of  0.56 and arithmetic mean of  176.83. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
120.53
Current Value
117.95
Quarterly Volatility
68.19638656
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Applied DNA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied DNA's main balance sheet or income statement drivers, such as Net Interest Income of 232.9 K, Interest Income of 232.9 K or Depreciation And Amortization of 838.7 K, as well as many indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 0.0 or PTB Ratio of 0.0424. Applied financial statements analysis is a perfect complement when working with Applied DNA Valuation or Volatility modules.
  
Build AI portfolio with Applied Stock
Check out the analysis of Applied DNA Correlation against competitors.

Latest Applied DNA's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Applied DNA Sciences over the last few years. It is Applied DNA's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Applied DNA's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Applied Operating Cycle Regression Statistics

Arithmetic Mean176.83
Geometric Mean155.87
Coefficient Of Variation38.57
Mean Deviation60.25
Median223.39
Standard Deviation68.20
Sample Variance4,651
Range201
R-Value(0.75)
Mean Square Error2,205
R-Squared0.56
Significance0.0006
Slope(10.07)
Total Sum of Squares74,412

Applied Operating Cycle History

2026 117.95
2025 120.53
2023 104.81
2022 22.35
2021 78.39

About Applied DNA Financial Statements

Applied DNA investors use historical fundamental indicators, such as Applied DNA's Operating Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Applied DNA. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle 120.53  117.95 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Applied Stock Analysis

When running Applied DNA's price analysis, check to measure Applied DNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied DNA is operating at the current time. Most of Applied DNA's value examination focuses on studying past and present price action to predict the probability of Applied DNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied DNA's price. Additionally, you may evaluate how the addition of Applied DNA to your portfolios can decrease your overall portfolio volatility.